HopeStage
Back to all studies
RecruitingNCT04480918

Treatments used for treatment-resistant depression

About this titleRead the official source — NCT04480918
Observational studyAges 18–99United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 99 years.

Listed locations
Iowa CitySee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: November 2, 2020
Recruitment status
Recruiting
Enrollment listed in the registry
1,000
Sponsor
Mark Niciu
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
DEVICE, Medication / drug
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 99 Years
Official registry ID
NCT04480918
Official title
Show the full official title

University of Iowa Interventional Psychiatry Service Patient Registry

Recruitment & locations

Currently recruiting

Iowa City

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Mark Niciu.

Does this study involve medication?

Yes. The study involves medication, including ketamine and Esketamine.

Who can participate?

Listed age limits: 18 years to 99 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies